These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 18019951)

  • 1. Medicare Advantage and the impact of Medicare HMOs on inpatient utilization.
    Minott J
    Find Brief; 2007 Oct; 10(9):1-3. PubMed ID: 18019951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare HMO impact on utilization at the end of life.
    Fonkych K; O'Leary JF; Melnick GA; Keeler EB
    Am J Manag Care; 2008 Aug; 14(8):505-12. PubMed ID: 18690766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of HMOs on the inpatient utilization of medicare beneficiaries.
    Dhanani N; O'Leary JF; Keeler E; Bamezai A; Melnick G
    Health Serv Res; 2004 Oct; 39(5):1607-27. PubMed ID: 15333125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of medicare health maintenance organizations on hospitalization rates for ambulatory care-sensitive conditions.
    Zeng F; O'Leary JF; Sloss EM; Lopez MS; Dhanani N; Melnick G
    Med Care; 2006 Oct; 44(10):900-7. PubMed ID: 17001260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Medicare-HMO revolving door--the healthy go in and the sick go out.
    Morgan RO; Virnig BA; DeVito CA; Persily NA
    N Engl J Med; 1997 Jul; 337(3):169-75. PubMed ID: 9219704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inpatient utilization by dual Medicare-Medicaid eligibles in Medicare risk HMOs and fee for service, California, 1991-1996.
    Sloss EM; Dhanani N; O'Leary JF; Lopez MS; Melnick G
    Manag Care Interface; 2004 Dec; 17(12):30-4, 41. PubMed ID: 15656377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do HMOs reduce preventable hospitalizations for Medicare beneficiaries?
    Basu J; Mobley LR
    Med Care Res Rev; 2007 Oct; 64(5):544-67. PubMed ID: 17881621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of HMOs on fee-for-service health care expenditures: evidence from Medicare revisited.
    Batata A
    J Health Econ; 2004 Sep; 23(5):951-63. PubMed ID: 15353188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Medicare HMOs still reduce health services use after controlling for selection bias?
    Mello MM; Stearns SC; Norton EC
    Health Econ; 2002 Jun; 11(4):323-40. PubMed ID: 12007164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report finds Medicare HMO members are younger, healthier and lower cost than FFS seniors.
    Public Sect Contract Rep; 1997 Nov; 3(11):174-5. PubMed ID: 10175566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients.
    Potosky AL; Merrill RM; Riley GF; Taplin SH; Barlow W; Fireman BH; Lubitz JD
    Health Serv Res; 1999 Jun; 34(2):525-46. PubMed ID: 10357289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conducting research on the Medicare market: the need for better data and methods.
    Wong HS; Hellinger FJ
    Health Serv Res; 2001 Apr; 36(1 Pt 2):291-308. PubMed ID: 11327178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of Medicare health care delivery systems with stage at diagnosis and survival for patients with melanoma.
    Kirsner RS; Wilkinson JD; Ma F; Pacheco H; Federman DG
    Arch Dermatol; 2005 Jun; 141(6):753-7. PubMed ID: 15967922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare HMOs: who joins and who leaves?
    Virnig BA; Morgan RO; DeVito CA; Persily NA
    Am J Manag Care; 1998 Apr; 4(4):511-8. PubMed ID: 10179910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How the elderly fare in HMOs: outcomes from the Medicare competition demonstrations.
    Retchin SM; Clement DG; Rossiter LF; Brown B; Brown R; Nelson L
    Health Serv Res; 1992 Dec; 27(5):651-69. PubMed ID: 1464538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies find wide variation in service utilization among Medicare risk, FFS patients.
    Public Sect Contract Rep; 1997 Aug; 3(8):123-5. PubMed ID: 10174880
    [No Abstract]   [Full Text] [Related]  

  • 17. Service-level selection by HMOs in Medicare.
    Cao Z; McGuire TG
    J Health Econ; 2003 Nov; 22(6):915-31. PubMed ID: 14604553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare, managed care, and vision services to the elderly.
    Soroka M
    Med Interface; 1995 Jun; 8(6):118-22, 125, 141. PubMed ID: 10142941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of functional outcomes after hip fracture in group/staff HMOs and fee-for-service systems.
    Coleman EA; Kramer AM; Kowalsky JC; Eckhoff D; Lin M; Hester EJ; Morgenstern N; Steiner JF
    Eff Clin Pract; 2000; 3(5):229-39. PubMed ID: 11185328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing mortality and time until death for medicare HMO and FFS beneficiaries.
    Maciejewski ML; Dowd B; Call KT; Feldman R
    Health Serv Res; 2001 Feb; 35(6):1245-65. PubMed ID: 11221818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.